Calliditas Therapeutics announces full FDA approval of TARPE

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Stockholm , Sweden , Bonnie Schneider , Renee Aguiar Lucander , Richard Lafayette , Drug Administration , Igan Foundation , Company Phase , Mckesson , Calliditas Therapeutics , Nasdaq Stockholm , Important Safety Information , Enrollment Form , Full Prescribing , Primary Immunoglobulin ,